Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes

about

The Use of Flow Cytometry in Myelodysplastic Syndromes: A Review.

P2860

Q47145316-063496DB-892A-41CD-B2F6-9268EDCB4947

P2860

Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes

Item

http://www.wikidata.org/entity/Q26742112

description

2016 nî lūn-bûn

@nan

2016 թուականին հրատարակուած գիտական յօդուած

@hyw

2016 թվականին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes

@ast

Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes

@en

Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes

@nl

type

Item

label

Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes

@ast

Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes

@en

Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes

@nl

prefLabel

Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes

@ast

Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes

@en

Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes

@nl

P1476

Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes

@en

P2093

Carmen Mariana Aanei

http://www.w3.org/2001/XMLSchema#string

Denis Guyotat

http://www.w3.org/2001/XMLSchema#string

Emmanuelle Tavernier

http://www.w3.org/2001/XMLSchema#string

Lydia Campos Catafal

http://www.w3.org/2001/XMLSchema#string

Tiphanie Picot

http://www.w3.org/2001/XMLSchema#string

P2860

Myelodysplastic Syndromes Diagnosis: What Is the Role of Molecular Testing?

Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes

CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (alpha v beta 3)

Clinical utility of multiparameter flow cytometry in the diagnosis of 1013 patients with suspected myelodysplastic syndrome: correlation to cytomorphology, cytogenetics, and clinical data.

A Novel Method to Assess Bone Marrow Purity is Useful in Determining Blast Percentage by Flow Cytometry in Acute Myeloid Leukemia and Myelodysplasia.

Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study

Serial assessment of suspected myelodysplastic syndromes: significance of flow cytometric findings validated by cytomorphology, cytogenetics, and molecular genetics.

Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference.

Reticulocyte maturity as an indicator for estimating qualitative abnormality of erythropoiesis.

Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study.

P304

161

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

483249

http://www.w3.org/2001/XMLSchema#string

P356

10.3389/FONC.2016.00161

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27446807

http://www.w3.org/2001/XMLSchema#string

P921

flow cytometry

P932

4921489

http://www.w3.org/2001/XMLSchema#string

Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes

about

P2860

P2860

Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P3181

P356

P407

P478

P577

P698

P921

P932

P3181

P356

P1433

P1476

P2093

P2860

P304

P31

P3181

P356

P407

P478

P577

P698

P921

P932